Table 6.

Psychotropic drug treatment

Pain medication (n=31; 16% of PWAD)

metamizole (n=21; 11%); fentanyl (n=6; 3%); paracetamol (n=3; 2%); tilidine+naloxone (n=3; 2%); buprenorphine(n=2; 1%); morphine (n=2; 1%); cannabinoid (n=1; 0.5%); oxycodone (n=1; 0.5%);

Antiepileptics (n= 39; 21% of PWAD)

levetiracetam (n=19; 10%); valproic acid (n=7; 4%); pregabalin (n=6; 3%); lamotrigine (n=4; 2%); gabapentin (n=2; 1%); brivaracetam (n=1; 0.5%); carbamazepine (n=1; 0.5%); clonazepam(n=1; 0.5%); oxcarbazepine (n=1; 0.5%)

Antipsychotics (n=74, 39% of PWAD)

risperidone (n=24; 13%,); quetiapine (n=23; 12%); pipamperon(n=18; 9%); melperone(n=11; 6%); aripiprazole (n=5; 3%); clozapine (n=2; 1%); haloperidol(n=2; 1%); olanzapine (n=2; 1%); prothipendyl (n=2; 1%); zuclopenthixol (n=2; 1%); amisulpride (n=1; 0.5%); sulpiride (n=1; 0.5%); tiapride(n=1; 0.5%);

Anxiolytics (n=15, 8% of PWAD)

lorazepam (n=13; 7%); hydroxyzine (n=1; 0.5%); oxazepam (n=1; 0.5%);

Hypnotics (n=12, 6%)

zolpidem (n=4; 2%); melatonin (n=3; 2%); promethazine (n=2; 1%); zopiclone (n=2; 1%)

Antidepressants (n=65, 34% of PWAD)

mirtazapine (n=18; 9%,); sertraline (n=17; 9%); citalopram (n=11; 6%); escitalopram (n=7; 4%); duloxetine (n=5; 3%); venlafaxine (n=3; 2%); paroxetine(n=2; 1%); trazodone (n=2;1%); agomelatine (n=1; 0.5%); doxepin (n=1; 0.5%); tranylcypromine (n=1; 0.5%)

Antidementia drugs (n=53, 28% of PWAD)

memantine (n=27; 14%); donepezil (n=18; 9%); rivastigmine (n=11; 6%); gingko(n=3; 2%); galantamine (n=1; 0.5%)